The KAAACI Standardization Committee Report on the procedure and application of fractional exhaled nitric oxide measurement.
10.4168/aard.2017.5.4.185
- Author:
Jae Woo KWON
1
;
Woo Jung SONG
;
Min Hye KIM
;
Kyung Hwan LIM
;
Min Suk YANG
;
Jae Woo JUNG
;
Jeongmin LEE
;
Dong In SUH
;
Yoo Seob SHIN
;
Sae Hoon KIM
;
Sang Heon KIM
;
Byung Jae LEE
;
Sang Heon CHO
Author Information
1. Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.
- Publication Type:Review
- Keywords:
Nitric oxide;
Diagnostic techniques and procedures;
Asthma;
Reference standards
- MeSH:
Asthma;
Bronchitis;
Diagnosis;
Diagnostic Techniques and Procedures;
Eosinophils;
Inflammation;
Nitric Oxide*
- From:Allergy, Asthma & Respiratory Disease
2017;5(4):185-192
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Fractional exhaled nitric oxide (FeNO) is a biomarker for type 2 inflammation in the airways, and its measurement has the distinct strengths of being simple, rapid, convenient, and reproducible. Since the discovery of FeNO in the 1990s, its measurement tools have been extensively developed and validated by several researchers. In particular, FeNO showed the potential to support the diagnosis of asthma and eosinophilic bronchitis. Since it has begun to be widely utilized in clinical research areas as well as daily practice, we summarized the standardized diagnostic procedures and suggested the clinical application of FeNO measurement in Korean population.
